U.S. Stem Cell Ruling Invites Asian Competition
Print
Email
The ink had barely dried on last week's U.S. court decision barring the National Institutes of Health from funding embryonic stem cell grants when I received this message from the second annual Stem Cells Asia Regenerative Medicine Congress, which meets in Seoul on October 26 through 28:
"Dear Jonathan Moreno,
—‰'Halt to U.S. Stem Cell Funding May Thwart Search for New Cures' -- Bloomberg News
"This is one of the most pertinent reasons why stakeholders of the stem cells arena are now moving to Asia to leverage on Asia's laissez-faire regulations and capitalize on Asia's growth potential in stem cell research and application."
And I was in fact quoted in that Bloomberg News story as follows: "This is a catastrophe. "...It's now possible that the United States is now taken out of embryonic stem cell research." Read more here.
This article was originally published in San Jose Mercury.
To speak with our experts on this topic, please contact:
Print: Katie Peters (economy, education, and health care)
202.741.6285 or kpeters@americanprogress.org
Print: Christina DiPasquale (foreign policy and security, energy)
202.481.8181 or cdipasquale@americanprogress.org
Print: Laura Pereyra (ethnic media, immigration)
202.741.6258 or lpereyra@americanprogress.org
Radio: Anne Shoup
202.481.7146 or ashoup@americanprogress.org
TV: Lindsay Hamilton
202.483.2675 or lhamilton@americanprogress.org
Web: Andrea Peterson
202.481.8119 or apeterson@americanprogress.org
Site-Wide and Issue-Specific RSS Feeds